UniProtKB/Swiss-Prot Q14690: Variant p.Leu1216Phe

Protein RRP5 homolog
Gene: PDCD11
Feedback?

Variant information Variant position:

1216 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Leucine (L) to Phenylalanine (F) at position 1216 (L1216F, p.Leu1216Phe). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and hydrophobic (L) to large size and aromatic (F) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs2986014 [ dbSNP | Ensembl ]

Sequence information Variant position:

1216 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

1871 The length of the canonical sequence.
Location on the sequence:

KFRVGQALRATVVGPDSSKT L LCLSLTGPHKLEEGEVAMGR The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         KFRVGQALRATVVGP-DSSKTLLCLSLTGPHK-------LEEGEVAMGR

Mouse                         KFQVGQAIEATVVDP-DVPRAFLCLSLIGPYR-------LE

Bovine                        KFQIGQALKATVVGPAESSKAFLCLSLIGPHK-------LK

Drosophila                    -----------------ISNKKLDIAHISPS----------

Baker's yeast                 VFPLGSALQVKVA---SIDREHGFVNAIGKSHVDINMSTIK

Fission yeast                 HFFLGKAIKCYVV---NAE-DSITLSAIGPLQ---GFENLT

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	2 – 1871	Protein RRP5 homolog
Domain	1149 – 1222	S1 motif 10

Literature citations
Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1.
Nagase T.; Seki N.; Ishikawa K.; Tanaka A.; Nomura N.;
DNA Res. 3:17-24(1996)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]; VARIANT PHE-1216; The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1442; VARIANT PHE-1216;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.